Market revenue in 2023 | USD 202.1 million |
Market revenue in 2030 | USD 359.1 million |
Growth rate | 8.6% (CAGR from 2023 to 2030) |
Largest segment | Volumetric infusion pumps |
Fastest growing segment | Insulin Infusion Pumps |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Volumetric Infusion Pumps, Syringe Infusion Pumps, Insulin Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Implantable Infusion Pumps, Other Infusion Pumps |
Key market players worldwide | Baxter International Inc, B. Braun, Medtronic PLC, Micrel Medical Devices, Boston Scientific Corp, Fresenius SE & Co KGaA, Roche Holding AG, Tandem Diabetes Care Inc, Terumo Corp, Moog Inc A, IRadimed Corp, CareFusion, Smiths Group PLC, Mindray Medical International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous infusion pumps market will help companies and investors design strategic landscapes.
Volumetric infusion pumps was the largest segment with a revenue share of 16.82% in 2023. Horizon Databook has segmented the France intravenous infusion pumps market based on volumetric infusion pumps, syringe infusion pumps, insulin infusion pumps, enteral infusion pumps, ambulatory infusion pumps, patient-controlled analgesia infusion pumps, implantable infusion pumps, other infusion pumps covering the revenue growth of each sub-segment from 2018 to 2030.
According to Healthcare IT, France has a growing elderly population, which is increasing the need for infusion pumps in hospitals. Moreover, there has been a 5% to 10% increase in patients being treated in homecare settings, which indicates the increase in demand for ambulatory infusion pumps.
Cancer is the leading cause of death in France, accounting for 28.5% of all deaths in 2018, followed by cardiovascular diseases, which accounted for 25%. Thus, the overall demand for advanced infusion pumps is on the rise, which is expected to fuel the market.
France has a well-built infrastructure for healthcare and greater accessibility of medical services. The country has favorable insurance and reimbursement policies, which is enabling a faster growth rate for the market. Data protection regulations continue to inhibit the role of technologies for infusion systems amid the trend of Internet of Medical Things (IOMT) and can be a hurdle for the market.
Horizon Databook provides a detailed overview of country-level data and insights on the France intravenous infusion pumps market , including forecasts for subscribers. This country databook contains high-level insights into France intravenous infusion pumps market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account